Description
A special ad hoc panel of scientific leaders in clinical hypertension research and clinical trials in cardiovascular diseases (CVD) was convened in Bethesda, Maryland, on January 16, 2007. The Institute asked the expert panel to:
- Critically examine relevant research developments since 2003;
- Decide whether they agree with the 2003 NHLBI Workshop recommendation1 that the most important trial question is whether treating to a systolic blood pressure goal lower than the currently recommended goal will reduce cardiovascular (CVD) mortality and morbidity (“lower-goal trial”);
- If they agree, consider critical design features for such a trial;
- If they do not agree, decide on the highest priority alternative.
The charge to the panel was to recommend a single hypertension trial that the NHLBI should initiate based on the following four evaluation criteria:
- Scientific importance of the research question
- Potential impact on clinical practice and public health
- Low likelihood of being addressed by industry without NIH involvement
- Feasibility and timeliness of a clinical events trial
Complete Meeting Report (PDF file, 13 pages, 102 K)